Ekso Bionics Holdings, Inc. Common Stock
NASDAQ: CHRN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Scott G. Davis
- Employees
- 55
- Headquarters
- Dallas, United States
- IPO year
- 2026
- Market cap
- $62.9M
- Website
- http://www.eksobionics.com
Loading CHRN…
Loading profile data…Frequently asked questions about CHRN
What does Ekso Bionics Holdings, Inc. Common Stock (CHRN) do?
Ekso Bionics Holdings, Inc., which began operations on January 30, 2012, and is headquartered in San Rafael, California, specializes in developing, refining, and marketing advanced exoskeleton technology. These innovative systems are currently applied in both the medical and industrial fields.
Where does CHRN trade?
Ekso Bionics Holdings, Inc. Common Stock (CHRN) trades on the NASDAQ Global Market.
What sector is CHRN in?
Ekso Bionics Holdings, Inc. Common Stock (CHRN) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Ekso Bionics Holdings, Inc. Common Stock?
Scott G. Davis is the chief executive officer of Ekso Bionics Holdings, Inc. Common Stock (CHRN).
Where is Ekso Bionics Holdings, Inc. Common Stock headquartered?
Ekso Bionics Holdings, Inc. Common Stock is headquartered in United States.
Does CHRN pay a dividend?
Ekso Bionics Holdings, Inc. Common Stock (CHRN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CHRN go public?
Ekso Bionics Holdings, Inc. Common Stock (CHRN) completed its initial public offering in 2026.